When is Aidoc the better choice?

It runs many detection models across an imaging estate through an operating system handling normalisation, monitoring and governance for every model on it. The 2026 clearance covers a double digit set of acute indications from a single named foundation model, with regulator reviewed performance behind it. For a health system standardising clinical AI across modalities, the infrastructure survives whichever algorithms get replaced.

When is Heartflow the better choice?

The coronary computed tomography analysis changes a specific downstream decision, whether a patient needs invasive testing, rather than reordering a worklist. The cardiac evidence base is deep and the outcome moved is measurable in both cost and avoided procedural risk. For a cardiology service the question is who goes to the catheterisation laboratory, and that is exactly what this answers.

Aidoc vs Heartflow

Last VerifiedAugust 4, 2026

Verdict

A platform against a single disease analysis, and they are not really alternatives. Aidoc runs detection models across an imaging estate through an operating system handling normalisation, monitoring and governance, with a 2026 clearance covering many acute indications from one named foundation model. Heartflow analyses coronary computed tomography to quantify plaque and stenosis, changing whether a patient goes to the catheterisation laboratory at all, with a deep cardiac evidence base and its own reimbursement route. The economics differ in kind: one is a platform licence, the other is a per study analysis that bills. A cardiology service buys Heartflow whatever else it runs; the enterprise question is whether Aidoc becomes the layer everything else sits on.

Select Aidoc if

It runs many detection models across an imaging estate through an operating system handling normalisation, monitoring and governance for every model on it.
The 2026 clearance covers a double digit set of acute indications from a single named foundation model, with regulator reviewed performance behind it.
For a health system standardising clinical AI across modalities, the infrastructure survives whichever algorithms get replaced.

Select Heartflow if

The coronary computed tomography analysis changes a specific downstream decision, whether a patient needs invasive testing, rather than reordering a worklist.
The cardiac evidence base is deep and the outcome moved is measurable in both cost and avoided procedural risk.
For a cardiology service the question is who goes to the catheterisation laboratory, and that is exactly what this answers.

Attribute Matrix

Side by Side

Axis	A Aidoc	H Heartflow
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.

Aidoc vs AIRS Medical→Aidoc vs Annalise.ai→Aidoc vs Bunkerhill Health→Aidoc vs Gleamer→Aidoc vs HOPPR→Aidoc vs Lunit→Aidoc vs Qure AI→Aidoc vs Rad AI→Aidoc vs Subtle Medical→Heartflow vs Viz.ai→

Disclosure

These sit at different layers, one an enterprise platform and the other a single disease analysis with its own reimbursement pathway, so a health system may run both and the comparison is about sequencing rather than selection. Neither publishes subgroup performance, and in cardiac imaging that gap matters because plaque characterisation evidence historically under represents women. Neither publishes pricing, and the economics differ in kind: a platform licence against a per study analysis with a billing route attached.